APRA won’t launch appeal against IOOF (ASX:IFL) - Sequoia Direct Pty Ltd

18OctOctober 18, 2019

APRA won’t launch appeal against IOOF (ASX:IFL)

Wealth Manager, IOOF (ASX:IFL) has announced the Australian Prudential Regulation Authority will not appeal the Federal Court's decision to dismiss its case against IOOF after the deadline for the regulator to lodge an appeal passed.

The deadline for APRA to lodge an appeal was due to lapse today and APRA has announced that it will not appeal the matter.

The Federal Court dismissed the APRA attack on the wealth management company in a judgement last month, calling its case "unpersuasive" and ordering the regulator to pay costs.

IOOF says it continues to work towards completion of the ANZ P&I business acquisition while supporting positive member outcomes, underpinned by stronger governance and higher standards.

Shares in IOOF (ASX:IFL) are trading 3.69 per cent higher at $7.31.

Copyright 2019 – Finance News Network

Source: Finance News Network

Related Posts

29AprApril 29, 2021

Stocks of the Hour: Cleanaway, Bingo and Tabcorp

27 Apr 2021 - A snapshot of top company news for the hour, featuring Cleanaway (ASX:CWY), Bingo (ASX:BIN) and Tabcorp (ASX:TAH).

12NovNovember 12, 2020

Bellevue Gold (ASX:BGL) increases estimates at Bellevue Gold Project

11 Nov 2020 - Bellevue Gold (ASX:BGL) is pleased to announce that the Indicated Resource at its Bellevue Gold Project in Western Australia has increased by 20 per cent to 1.04 million ounces gold at 11.4 gold per tonne.

15AprApril 15, 2021

Recce Pharmaceticals (ASX:RCE) lead compound ready to start clinical trials for topical wound application

15 Apr 2021 - Recce Pharmaceticals’ (ASX:RCE) lead compound RECCE® 327 has been registered in the Australian New Zealand Clinical Trial Registry (ANZCTR) for its Phase I/II Topical Burns Study in humans.

03SepSeptember 3, 2019

Cynata Therapeutics see their organ rejection study published

04 Sep 2019 - Clinical-stage biotechnology company Cynata Therapeutics (ASX:CYP) is excited to have a scientific paper published on the efficacy of Cymerus MSCs in a preclinical model of organ transplant rejection.

21DecDecember 21, 2020

Lifestyle communities (ASX:LIC) to buy a new site in Victoria

21 Dec 2020 - Lifestyle communities (ASX:LIC) is looking to buy a new site in Rockbank in Victoria.

28NovNovember 28, 2019

Wagners (ASX:WGN) secures contract with Adani Mining

28 Nov 2019 - Wagners (ASX:WGN) has secured a contract with Adani Mining for the operation of South Back Creek Quarry, near Clermont in Queensland.

07AugAugust 7, 2021

Stocks of the Hour: BWP Trust, GUD & ALE Property

04 Aug 2021 - A snapshot of some of the news that broke today featuring BWP Trust (ASX:BWP), GUD (ASX:GUD), ALE Property (ASX:LEP)

06AprApril 6, 2021

Incitec Pivot (ASX:IPL) delay Waggaman plant reopening

06 Apr 2021 - Incitec Pivot (ASX:IPL) has delayed the start of operations at its Waggaman ammonia plant after the plant was brought down by a dry gas seal failure and vibrations in the turbine on the induced draft fan.

28JanJanuary 28, 2020

Electro Optic Systems Holdings (ASX:EOS) acquires US space communications business

28 Jan 2020 - Electro Optic Systems Holdings (ASX:EOS) has executed an agreement to acquire all of the business and assets of Audacy Corporation, a space communications company based in the US.

16SepSeptember 16, 2019

Sims shares plunge 15% on 1H FY20 downgrade

16 Sep 2019 - Sims Metal Management (ASX:SGM) has today announced that the recent and significant falls in ferrous and non-ferrous prices will negatively impact 1H FY20 and the result will be materially lower than 1H FY19.